Replies to post #214503 on Amarin Corp Plc (AMRN)

[Atom0aks]

Thank you Atom0aks. I am familiar with Acasti and Capre. Looks like they are attempting to get grandfathered into Vascepa’s label or something like that

No probs.

Looking through the original tweets, it looks like the Acasti study is using a different placebo and so I think the OP was making the argument that the TRILOGY study might shed new light on the effect of mineral oil.

[ferretmoney]

Acasti will never succeed in getting a cardiovascular label (piggybacking on the Vascepa label). It’s a relatively small study (600 some participants) over a relatively short term (26 weeks). If they succeed in lowering triglycerides, so what? There is no established causal relationship. If they want the label they will have to run a large scale long-term outcomes study.